ReviewAdvances in chronic kidney disease2013
Optimal nutrition in hemodialysis patients.
Review in Advances in chronic kidney disease, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Nutritional Strategies to Address Malnutrition in Dialyses Patients: A Systematic Review.Nutrients · 2025Pooled it
- The effect of extended hemodialysis on nutritional parameters: a systematic review.Journal of nephrology · 2022Pooled it
- The Effect of Exercise on Nutritional Status and Body Composition in Hemodialysis: A Systematic Review.Nutrients · 2020Pooled it
- Effects of keto acid supplements on Chinese patients receiving maintenance hemodialysis: a prospective, randomized, controlled, single-center clinical study.Chinese medical journal · 2020Trial
- Insulin resistance is a significant determinant of sarcopenia in advanced kidney disease.American journal of physiology. Endocrinology and metabolism · 2018Trial
- Mind the Gut: Cognitive Decline, Microbiota, and Nutrition-Related Modulators in Older Adults with Chronic Kidney Disease.Nutrients · 2026Review
- Nutritional Challenges in Hemodialysis: A Perspective from Albania.The Eurasian journal of medicine · 2026Article
- Plasma Metabolite Profiles Between In-Center Daytime Extended-Hours and Conventional Hemodialysis.Kidney360 · 2025Article
- Sarcopenia in Chronic Kidney Disease: A Narrative Review from Pathophysiology to Therapeutic Approaches.Biomedicines · 2025Review
- Prevalence and risk factors of malnutrition among patients receiving hemodialysis in a tertiary level hospital in Mauritius.The Journal of international medical research · 2024Article
- Progress in the study of nutritional status and selenium in dialysis patients.Annals of medicine · 2023Review
- Article
- The triglyceride-glucose index as a novel marker associated with sarcopenia in non-diabetic patients on maintenance hemodialysis.Renal failure · 2022Article
- Article
- A Comparative Study of the Efficacy of an Intervention with a Nutritional Supplement for Patients with Chronic Kidney Disease: A Randomized Trial.Journal of clinical medicine · 2022Article
- Serum Adropin Levels in Patients on Hemodialysis.Life (Basel, Switzerland) · 2021Article
- Serum trace metal association with response to erythropoiesis stimulating agents in incident and prevalent hemodialysis patients.Scientific reports · 2020Article
- Comparison of dietary intake patterns in hemodialysis patients by nutritional status: A cross-sectional analysis.Kidney research and clinical practice · 2020Article
- Markers of protein-energy wasting and physical performance in haemodialysis patients: A cross-sectional study.PloS one · 2020Article
- The relationship of blood neutrophil-to-lymphocyte ratio with nutrition markers and health outcomes in hemodialysis patients.International urology and nephrology · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
Protein-energy wasting (PEW) is highly prevalent in patients undergoing maintenance hemodialysis (MHD). It is important to note that there is a robust association between the extent of PEW and the risk of hospitalization and death in these patients, regardless of the nutritional marker used. The multiple etiologies of PEW in advanced kidney disease are still being elucidated. Apart from the multiple mechanisms that might lead to PEW, it appears that the common pathway for all of the derangements is related to exaggerated protein degradation along with decreased protein synthesis. The hemodialysis procedure per se is an important contributor to this process. Metabolic and hormonal derangements such as acidosis, inflammation, and resistance to anabolic properties of insulin resistance and growth hormone are all implicated for the development of PEW in MHD patients. Appropriate management of MHD patients at risk for PEW requires a comprehensive combination of strategies to diminish protein and energy depletion and to institute therapies that will avoid further losses. The mainstay of nutritional treatment in MHD patients is provision of an adequate amount of protein and energy, using oral supplementation as needed. Intradialytic parenteral nutrition should be attempted in patients who cannot efficiently use the gastrointestinal tract. Other anabolic strategies such as exercise, anabolic hormones, anti-inflammatory therapies, and appetite stimulants can be considered as complementary therapies in suitable patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.